CT-Perfusion for Neurological Diagnostic Evaluation

NAActive, not recruitingINTERVENTIONAL
Enrollment

333

Participants

Timeline

Start Date

April 25, 2017

Primary Completion Date

February 22, 2021

Study Completion Date

August 31, 2024

Conditions
Neurological Determination of Death
Interventions
DIAGNOSTIC_TEST

Neurological Diagnostic Evaluation

"Clinical Data:~* Demographic data~* Daily data (clinical exams, laboratory data)~* Drug administration~* Additional clinical or ancillary neurological determination test~Diagnostic Intervention:~* CT-Perfusion~* CT-Angiography reconstructions~Reference Standard:~\- Clinical Neurological Exam~Blood Samples (Pharmacokinetics, Inflammatory \& Nanovesicles Parameters):~* At the time of patient enrolment~* 6 hours after patient enrolment~* At the time of the clinical neurological exam~Secondary Outcome measures at 6 months:~* extended Glasgow Outcome Scale (GOSe)~* modified Rankin Scale (mRS)"

Trial Locations (14)

Unknown

Foothills Medical Centre, Calgary

Winnipeg Health Sciences Centre, Winnipeg

Queen Elizabeth II Health Sciences Centre, Halifax

Hamilton Health Sciences Center, Hamilton

Kingston General Hospital, Kingston

London Health Sciences Centre, London

The Ottawa Hospital, Ottawa

St-Michael's Hospital, Toronto

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal

McGill University Health Centre, Montreal

Montreal Neurological Institute and Hospital, Montreal

CHU de Québec - Université Laval, Québec

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke

L6R 3J7

William Osler Health System, Brampton

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT03098511 - CT-Perfusion for Neurological Diagnostic Evaluation | Biotech Hunter | Biotech Hunter